1318 FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C IS NOT INFLUENCED BY IL28B POLYMORPHISMS
Alessio Aghemo, M. Colombo(University of Milan), Sergio Abrignani(Istituto Nazionale Genetica Molecolare), Cristina Cheroni(Human Technopole), Raffaele De Francesco(University of Milan), R. Soffredini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Marco Crimi(Istituto Nazionale Genetica Molecolare), Francesco Marabita(Karolinska University Hospital), Maria Grazia Rumi(University of Milan), Rossana Scavelli(Istituto Nazionale Genetica Molecolare), Stella De Nicola(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 3
Related Papers
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
|European Journal of Immunology|2021|506